Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-21

Clinical Trial Update: STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) Patients [Phase 3]

View source ↗

Summary

Phase 3 STIMULATE trial evaluating anemia correction and health-related quality of life in elderly patients with chronic kidney disease. The study sponsored by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amgen | Conditions: Anemia, Chronic Kidney Disease | Phase 3 | Status: TERMINATED | Results posted: 2014-05-21